08580518 · Active · incorporated 13 years, 4 months ago · Abingdon
Biotech AI Biotech & Life Sciences Drug Discovery Series B+
A privately owned biotech company focused on developing therapeutics for neurodegenerative diseases, based on their novel molecule T14.
Neurobio is a private limited company registered at Companies House under number 08580518, incorporated on 21 June 2013, with a registered office in Abingdon, Oxfordshire. Its current status on the register is active. Its filed nature of business is other research and experimental development on natural sciences and engineering (SIC 72190). Sonde has indexed 153 filings for this company, including 14 funding rounds. Its most recent round closed in June 2026, raising £668k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 14 | Jun 2026 | £668k | £32.45 |
| Round 13 | Dec 2024 | £475k | £87.64 |
| Round 12 | Feb 2024 | £3.2m | £87.64 |
| Round 11 | Jan 2023 | £100k | £103.64 |
| Round 10 | Jun 2022 | £378k | £103.64 |
| Round 9 | Jun 2021 | £75k | £25.75 |
Showing the 6 most recent of 14 rounds.
Showing the 12 most recent of 153 filings.
See the complete cap table with every shareholder, founder tags, dilution across 91 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.